|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-5-14
|
|
pubmed:abstractText |
Posttransplant renal replacement therapy has been shown to be an independently significant risk factor for invasive fungal infections after liver transplantation. We assessed the efficacy of a lipid preparation of amphotericin B as prophylaxis for invasive fungal infections, directed toward liver transplant recipients requiring renal replacement therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
910-3
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11349726-Adult,
pubmed-meshheading:11349726-Aged,
pubmed-meshheading:11349726-Amphotericin B,
pubmed-meshheading:11349726-Cohort Studies,
pubmed-meshheading:11349726-Female,
pubmed-meshheading:11349726-Humans,
pubmed-meshheading:11349726-Incidence,
pubmed-meshheading:11349726-Lipids,
pubmed-meshheading:11349726-Liver Transplantation,
pubmed-meshheading:11349726-Male,
pubmed-meshheading:11349726-Middle Aged,
pubmed-meshheading:11349726-Mycoses,
pubmed-meshheading:11349726-Postoperative Complications,
pubmed-meshheading:11349726-Preventive Medicine,
pubmed-meshheading:11349726-Renal Replacement Therapy
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy.
|
|
pubmed:affiliation |
Veterans Affairs Medical Center and University of Pittsburgh, Thomas E. Starzl Transplantation Institute, PA 15240, USA.
|
|
pubmed:publicationType |
Journal Article
|
